Live Cell Imaging Market Focused Insights Report 2025-2030, Profiling Agilent Technologies, BD, Danaher, PerkinElmer, Merck KgaA, Thermo Fisher Scientific and Zeiss - ResearchAndMarkets.com

The "Live Cell Imaging Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The Live Cell Imaging Market was valued at USD 2.68 billion in 2024, and is projected to reach USD 4.44 billion by 2030, rising at a CAGR of 8.78%.

The global live cell imaging market report consists of exclusive data on 37 vendors. Agilent Technologies, BD, Danaher, PerkinElmer, Merck, Thermo Fisher Scientific, and Zeiss are some of the leading companies that accounted for the highest market share in the global live-cell imaging market. These vendors offer high-class and reliable live-cell imaging equipment, consumables, and software solutions that meet customers' requirements and international regulations.

Leading vendors are increasing the efficiency of their products and strengthening their market position. These companies have a strong brand image and wide geographical reach across the global market. Also, the adoption of various strategies, such as product launches, new product development with advanced technologies and tools, and acquisitions intensified the competition in the market. The adoption of such strategies by the vendors and their focus on expanding their capabilities have enabled them to gain a higher revenue share in the market.

RECENT VENDORS ACTIVITIES

• In 2025, Revvity developed and launched a revolutionary Phenologic.AI Software. This software is designed to redefine cellular imaging workflows for their harmony and Signal Image Artist software.
• In 2024, Leica Microsystems revealed TauSTED Xtend, a new STED microscopy approach that can enable extended multicolor live cell imaging easily at nanoscopic resolutions.
• In 2023, Thrive Biosciences launched a new integrated suit - CellAssist, of exciting and unique capabilities that significantly advance the field of live cell imaging.
• In 2023, Bruker signed an agreement to acquire Phasefocus Holding Limited, an optical cell imaging company that has expertise in imaging and image processing algorithms. This acquisition supports Bruker in the development of a novel optical microscope for a live cell imaging portfolio.
• In 2023, Bruker acquired ACQUIFER Imaging GmbH which was a pioneer in big-data management solutions for high-content microscopy and bioimaging.
• In 2023, Axion BioSystems, a pioneer company in live cell analysis tools development announced the full integration of CytoSMART Technologies.

KEY TAKEAWAYS

• By Product: The equipment segment holds the largest market share of over 51%. The segment is growing as they are widely used in cellular biology, drug research, development biology, and stem cell research and development.
• By Technique: The fluorescence microscopy segment shows the highest growth of 9.06% as they are widely preferred and used techniques for live cell imaging due to their capabilities to mark and analyze targeted cells.
• By Application: The cell biology segment accounts for the largest market share. Cell biology encompasses a broad range of research areas and applications, such as apoptosis, cell cycle and division, DNA damage, in-vitro studies, and others.
• By End-User: Pharma & biotech companies dominate the global live cell imaging market share. Growing research and development and growing attention towards personalized medicines development accelerating the demand for live-cell imaging solutions by biopharma companies.
• By Geography: In 2024, North America accounted for over 35% share of the global live cell imaging market. The demand for live cell imaging in North America has experienced a steady growth rate due to the increasing research and development (R&D) in cellular biology, and rapid development in cell and gene therapies.
• Growth Factor: The global live cell imaging market is set to grow due to the growing demand for live cell imaging in drug discovery and the rising application of live cell imaging in disease diagnosis.

MARKET TRENDS & DRIVERS

Leveraging AI and Big Data with Oblique Illumination Technology

The integration of big data and Artificial Intelligence (AI) completely changed the landscape of live cell optical imaging in recent years. AI and Big Data boost efficiency and expand the scope of insights gained. On another side, oblique illumination technology optimizes contrast, making cell structure sharper and enabling precise monitoring of changes during development and disease. Oblique illumination technology supports diverse applications, expanding its use in neuroscience, organ studies and 3D tissue cultures, vascular research, and pathology. The combination of big data analytics and AI algorithms also expands the application potential of new oblique illumination technology across various life sciences and drug discovery fields. With this ongoing trend in live cell imaging, AI and big data are expected to continue contributing to considerable progress in life sciences exploration.

Recent Advances in Fluorescent Probes for Live Cell Imaging

Live cell imaging with fluorescence microscopy has witnessed significant developments. It is a powerful and recognized technology for visualizing biological events in living cell samples with special resolution and high temporal. In addition, the development of fluorescent probes that emit far-red to near-infrared (NIR) fluorescence is beneficial for in-vivo imaging due to their low autofluorescence and high tissue permeability, as well as their suitability for multicolor imaging. This development of fluorescent probes and associated benefits are expected to deliver lucrative market growth opportunities.

Growing Demand for Live Cell Imaging In Drug Discovery

Live cell imaging is significantly useful for several aspects of the drug discovery and development pipeline such as kinetic studies and compound mode of action or to analyze the motion of cellular components. Furthermore, high-content imaging (HCI) and AI widely contribute to drug discovery and development, accelerated by the recent progress in deep neural networks. These factors are accelerating the demand for live cell imaging in drug discovery. For example, Revvity developed high-content screening systems, such as Operetta CLS and Opera Phenix that offer significant flexibility to run live cell assays which are highly required and used in drug discovery programs.

GEOGRAPHICAL ANALYSIS

North America dominates and holds the largest share of over 35% of the global live cell imaging market. North America is home to several small, medium, and large market players that widely promote live-cell imaging equipment, software, and consumables for clinical research and development for biopharma companies and academic & research institutes/centers. The US and Canada are two major countries that are highly engaged in cell biology and associated research, fueling the demand for live cell imaging solutions. The demand for live cell imaging in North America has experienced a steady growth rate due to the increasing research and development (R&D) in cellular biology, rapid development in cell and gene therapies, and growing applications in disease diagnosis and therapy developments.

COMPETITIVE LANDSCAPE

Key Vendors

• Agilent Technologies
• BD
• Danaher
• PerkinElmer
• Merck KgaA
• Thermo Fisher Scientific
• Zeiss

Other Prominent Vendors

• Axion BioSystems
• Aligned Genetics
• Bio-Rad Laboratories
• Blue-Ray Biotech
• Bruker
• Eppendorf
• Etaluma
• Evident
• Grace Bio-Labs
• ibidi GmbH
• Intelligent Imaging Innovations
• KEYENCE CORPORATION
• NanoEntek
• Molecular Devices
• Media Cybernetics
• Nanolive SA
• Nikon
• ONI
• Oxford Instruments
• Phase Focus
• Phase Holographic Imaging PHI AB
• The Proteintech Group
• Sartorius AG
• Sony Biotechnology
• Tomocube
• Tecan Trading AG
• Revvity
• RAMONA
• Thrive Bioscience
• Takasago Electric

   

Key Attributes:

Report Attribute	Details
No. of Pages	143
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$2.68 Billion
Forecasted Market Value (USD) by 2030	$4.44 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global

SEGMENTATION & FORECAST

• By Product
  • Equipment
  • Consumables & Accessories
  • Software
• By Technique
  • Fluorescence Microscopy
  • Confocal Microscopy
  • Transmitted Light Microscopy
  • Others
• By Application
  • Cell Biology
  • Drug Discovery
  • Development Biology
  • Stem Cell Research
• By End-User
  • Pharma & Biotech Companies
  • Academic & Research Institutes
  • Other
• By Geography
• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE

For more information about this report visit https://www.researchandmarkets.com/r/p78qqv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250505248441/en/